Venezuela has approved for use Russia’s single-shot Sputnik Light COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said on Saturday.
Developed by Moscow’s Gamaleya Institute, the slimmed-down vaccine, which the RDIF says is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and has been billed as a way to help vaccine supplies go further in countries with high infection rates.
Approval of the shot by Venezuela follows successful use of the two-dose Sputnik V vaccine in the country and
“will help accelerate the vaccination”
campaign, said Kirill Dmitriev, the head of the RDIF, which is responsible for marketing the vaccine abroad.
Featured image: illustration